Hsa_circ_0007494 suppresses prostate cancer progression via miR-616/PTEN axis

Shilong Zhang1, Xiangsheng Zhang1, Guoxiao Chen1

  • 1Department of Urology Surgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, 450003, Henan Province, China.

Insights

Circular RNAs (circRNAs) are crucial in prostate cancer (PCa). This study found hsa_circ_0007494 suppresses PCa by regulating miR-616 and PTEN, suggesting it as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) play a role in prostate cancer (PCa) pathogenesis.
  • The specific mechanisms of circRNAs in PCa progression remain largely unknown.

Purpose of the Study:

  • To investigate the role and mechanism of hsa_circ_0007494 in prostate cancer.
  • To explore hsa_circ_0007494 as a potential therapeutic target for PCa.

Main Methods:

  • Quantitative real-time PCR to assess hsa_circ_0007494 expression in PCa tissues and cell lines.
  • In vitro assays (proliferation, invasion) and in vivo tumor growth models to evaluate functional roles.
  • MiRNA sponge assays and rescue experiments to elucidate the molecular mechanism involving miR-616 and PTEN.

Main Results:

  • hsa_circ_0007494 expression was significantly downregulated in PCa tissues and cell lines.
  • Overexpression of hsa_circ_0007494 inhibited PCa cell proliferation, invasion, and tumor growth.
  • hsa_circ_0007494 acts as a molecular sponge for miR-616, upregulating its target gene PTEN.
  • PTEN silencing or miR-616 mimics reversed the tumor-suppressive effects of hsa_circ_0007494.

Conclusions:

  • hsa_circ_0007494 functions as a tumor suppressor in PCa by regulating the hsa_circ_0007494/miR-616/PTEN axis.
  • hsa_circ_0007494 holds potential as a novel therapeutic target for prostate cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K